# A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)

> **NCT00926185** · PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 230 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Lifitegrast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00926185
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-03
- **Primary completion:** 2010-02-18
- **Final completion:** 2010-02-18
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2021-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00926185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00926185, "A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT00926185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*